Dallah Healthcare Company (TADAWUL:4004)

Saudi Arabia · Delayed Price · Currency is SAR

72.15

-1.45 (-1.97%)

Oct 15, 2026, 3:19 PM AST

Market Cap	8.73B -44.5%
Revenue (ttm)	4.29B +20.9%
Net Income	442.98M -14.8%
EPS	3.62 -17.8%
Shares Out	120.96M
PE Ratio	19.93
Forward PE	14.77
Dividend	1.67 (2.31%)
Ex-Dividend Date	Aug 10, 2026

Volume	221,251
Open	73.75
Previous Close	73.60
Day's Range	71.55 - 75.05
52-Week Range	71.55 - 131.08
Beta	-0.47
Analysts	Buy
Price Target	103.97 (+44.1%)
Est. Earnings	Nov 10, 2026

About Dallah Healthcare Company

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical centres, complexes, and clinics; and the provision of manpower and support services. It also offers pharmaceuticals, cosmetics, consumables, equipment, and nutritional supplements, as well as medications, diagnostics, and medical technologies. In addition, the company provides personalized treatment plans, post-surgical recovery and chronic ... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1987

Country Saudi Arabia

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4004

Full Company Profile

Financial Performance

In 2025, Dallah Healthcare Company's revenue was 4.07 billion, an increase of 26.86% compared to the previous year's 3.21 billion. Earnings were 538.27 million, an increase of 14.23%.

Financial Statements

Analyst Summary

According to 10 analysts, the average rating for 4004 stock is "Buy." The 12-month stock price target is SAR 103.97, which is an increase of 44.10% from the latest price.

Price Target

SAR 103.97

(44.10% upside)

Analyst Consensus: Buy

Stock Forecasts